Abstract
The human Ether-a-go-go Related Gene (hERG) product has been identified as a central ion channel underlying both familial forms of elongated QT interval on the electrocardiogram and drug-induced elongation of the same QT segment. Indeed, reduced function of this potassium channel involved in the repolarization of the cardiac action potential can produce a type of life-threatening cardiac ventricular arrhythmias called Torsades de Pointes (TdP). Therefore, hERG inhibitory activity of newly synthetized molecules is a relevant structure-activity metric for compound prioritization and optimization in medicinal chemistry phases of drug discovery. Electrophysiology remains the gold standard for the functional assessment of ion channel pharmacology. The recent years have witnessed automatization and parallelization of the manual patch-clamp technique, allowing higher throughput screening on recombinant hERG channels. However, the multi-well plate format of automatized patch-clamp does not allow visual detection of potential micro-precipitation of poorly soluble compounds. In this chapter we describe bench procedures for the culture and preparation of hERG-expressing CHO cells for recording on an automated patch-clamp workstation. We also show that the sensitivity of the assay can be improved by adding a surfactant to the extracellular medium.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Roden DM (2016) Predicting drug-induced QT prolongation and torsades de pointes. J Physiol 594:2459–2468
Rampe D, Brown AM (2013) A history of the role of the hERG channel in cardiac risk assessment. J Pharmacol Toxicol Methods 68:136–122
Terstappen GC, Roncarati R, Dunlop J, Peri R (2010) Screening technologies for ion channel drug discovery. Future Med Chem 2:715–730
Mathes C (2006) QPatch: the past, present and future of automated patch clamp. Expert Opin Ther Targets 10:319–327
Crumb WJ Jr, Vicente J, Johannesen L, Strauss DG (2016) An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel. J Pharmacol Toxicol Meth 81:251–262
Pearlstein R, Vaz R, Rampe D (2003) Understanding the structure-activity relationship of the human Ether-a-go-go-Related Gene cardiac K+ channel. A model for bad behavior. J Med Chem 46:2017–2022
Kirsch GE, Trepakova ES, Brimecombe JC, Sidach SS, Erikson HD, Kochan MC, Shyjka LM, Lacerda AE, Brown AM (2004) Variability in the measurement of hERG potassium channel inhibition: effects of temperature and stimulus pattern. J Pharmacol Toxicol Methods 50:93–101
Snyders DJ, Chaudhary A (1996) High affinity open channel block by dofetilide of HERG expressed in a human cell line. Mol Pharmacol 49:949–955
Acknowledgments
The authors would like to thank David Rampe and Terence Appelqvist for their critical review of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Houtmann, S., Schombert, B., Sanson, C., Partiseti, M., Bohme, G.A. (2017). Automated Patch-Clamp Methods for the hERG Cardiac Potassium Channel. In: Gautier, JC. (eds) Drug Safety Evaluation. Methods in Molecular Biology, vol 1641. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7172-5_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7172-5_10
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7170-1
Online ISBN: 978-1-4939-7172-5
eBook Packages: Springer Protocols